Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A new study from the Kennedy Institute of Rheumatology reveals a role for blood vessels in promoting therapy resistance of cancer metastasis in bone.

Confocal image showing subtypes of blood vessels (red, green and white) in bone. The new research links certain types of blood vessel cells to therapy resistance in tumour metastasis.

The research led by Dr Anjali Kusumbe’s team at the Kennedy Institute and published in JCI Insight shows that cells called pericytes that attach to blood vessels can halt the growth of cancer cells that have travelled from the primary tumour to bones. 

The researchers found increased numbers of pericytes in bones following chemotherapy or radiation, together with more of the proteins they secrete that keep cancer cells in check. As chemotherapy targets actively diving cells, these findings suggest pericytes might promote resistance to therapy.

Speaking of the research, Anjali said, “This is an offshoot of our research programme on understanding the vascular maladaptation during ageing, bone diseases and cancer. Blood vessels provide inductive signals during organ growth and form nurturing niches for multiple adult stem cells in the body. Our study shows that the vascular niches in bone respond differentially to cancer therapies and secrete factors to protect cancer cells during treatments”.        

Treatment with cancer therapies caused blood vessels in bone to secrete more of a molecule called PDGF2, which activates pericytes. Anjali explains “We identified blood flow and PDGF as a regulator of pericyte expansion in bone during treatment with cancer therapies. Use of blood flow modulators in combination with conventional cancer therapies render disseminated tumour cells in bones susceptible to these therapies, providing a possible strategy to target these cells to prevent bone metastasis”.     

Pericytes became less effective at subduing cancer cells with age, which may explain why cancer returns in the bones of some patients many years after treatment. 

The researchers are now focusing their attention on identifying therapeutic targets in the bone marrow microenvironment for managing age-related metastatic relapse. 

The work was supported by the European Research Council, Leuka, Medical Research Council, Royal Society, CRUK Development Fund and the Kennedy Trust for Rheumatology Research.

Similar stories

Neutrophil molecular wiring revealed: transcriptional blueprint of short-lived cells

Researchers publish the first blueprint of transcriptional factors that control neutrophil-driven inflammation in Nature Immunology.

Exploring the link between joint injury and osteoarthritis

A new study published in The Lancet Rheumatology shows potential ways to predict how likely someone is to develop osteoarthritis after a knee injury.

Repurposed drug can induce remission of inflammatory arthritis

Researchers at the Kennedy Institute demonstrate that the drug decitabine can boost regulatory T cell responses.

Small mechanical forces in immune cells measured at unprecedented sensitivity

Oxford researchers have used advanced microscopy techniques to measure previously unseen forces generated by cells during an immune response; a breakthrough for mechanobiology and future advances in health and disease.

Oxford to collaborate with Janssen to map the cellular landscape of immune mediated disorders

The University of Oxford has entered into a strategic collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

Vascular loss shown to be the primary hallmark of aging

New Research from the Kusumbe group at the Kennedy Institute of Rheumatology identifies vascular attrition, marked by pericyte to fibroblast differentiation, as a primary hallmark of aging and highlights organ-specific vascular changes with age.